Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.47
CTRX's Cash to Debt is ranked lower than
59% of the 1684 Companies
in the Global Health Information Services industry.

( Industry Median: 24.11 vs. CTRX: 0.47 )
CTRX' s 10-Year Cash to Debt Range
Min: 0.26   Max: No Debt
Current: 0.47

Equity to Asset 0.57
CTRX's Equity to Asset is ranked higher than
62% of the 1630 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. CTRX: 0.57 )
CTRX' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.91
Current: 0.57

0.3
0.91
F-Score: 4
Z-Score: 3.68
M-Score: -2.12
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 3.00
CTRX's Operating margin (%) is ranked higher than
61% of the 1596 Companies
in the Global Health Information Services industry.

( Industry Median: 5.62 vs. CTRX: 3.00 )
CTRX' s 10-Year Operating margin (%) Range
Min: -32.17   Max: 19.04
Current: 3

-32.17
19.04
Net-margin (%) 1.77
CTRX's Net-margin (%) is ranked higher than
61% of the 1595 Companies
in the Global Health Information Services industry.

( Industry Median: 3.80 vs. CTRX: 1.77 )
CTRX' s 10-Year Net-margin (%) Range
Min: -41.12   Max: 16.86
Current: 1.77

-41.12
16.86
ROE (%) 5.34
CTRX's ROE (%) is ranked higher than
65% of the 1559 Companies
in the Global Health Information Services industry.

( Industry Median: 6.80 vs. CTRX: 5.34 )
CTRX' s 10-Year ROE (%) Range
Min: -153.84   Max: 19.26
Current: 5.34

-153.84
19.26
ROA (%) 3.28
CTRX's ROA (%) is ranked higher than
67% of the 1614 Companies
in the Global Health Information Services industry.

( Industry Median: 3.56 vs. CTRX: 3.28 )
CTRX' s 10-Year ROA (%) Range
Min: -46.68   Max: 10.38
Current: 3.28

-46.68
10.38
ROC (Joel Greenblatt) (%) 202.38
CTRX's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 1594 Companies
in the Global Health Information Services industry.

( Industry Median: 34.51 vs. CTRX: 202.38 )
CTRX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -140.24   Max: 649.05
Current: 202.38

-140.24
649.05
Revenue Growth (%) 66.70
CTRX's Revenue Growth (%) is ranked higher than
99% of the 1378 Companies
in the Global Health Information Services industry.

( Industry Median: 6.20 vs. CTRX: 66.70 )
CTRX' s 10-Year Revenue Growth (%) Range
Min: -9.7   Max: 142.7
Current: 66.7

-9.7
142.7
EBITDA Growth (%) 54.10
CTRX's EBITDA Growth (%) is ranked higher than
96% of the 1105 Companies
in the Global Health Information Services industry.

( Industry Median: 7.80 vs. CTRX: 54.10 )
CTRX' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 54.1
Current: 54.1

0
54.1
EPS Growth (%) 35.50
CTRX's EPS Growth (%) is ranked higher than
89% of the 1064 Companies
in the Global Health Information Services industry.

( Industry Median: 7.50 vs. CTRX: 35.50 )
CTRX' s 10-Year EPS Growth (%) Range
Min: -10.6   Max: 65.9
Current: 35.5

-10.6
65.9
» CTRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

CTRX Guru Trades in Q3 2013

Louis Moore Bacon 100,000 sh (New)
Jim Simons 929,970 sh (+1696.35%)
Pioneer Investments 312,937 sh (+47.13%)
Steven Cohen 71,401 sh (-27.52%)
» More
Q4 2013

CTRX Guru Trades in Q4 2013

Lee Ainslie 4,008,385 sh (New)
Paul Tudor Jones 150,000 sh (New)
Steven Cohen 1,664,986 sh (+2231.88%)
Pioneer Investments 386,905 sh (+23.64%)
Jim Simons 1,121,470 sh (+20.59%)
Louis Moore Bacon Sold Out
» More
Q1 2014

CTRX Guru Trades in Q1 2014

Diamond Hill Capital 153,943 sh (New)
Louis Moore Bacon 200,000 sh (New)
Vanguard Health Care Fund 4,221,183 sh (New)
Joel Greenblatt 9,664 sh (New)
Manning & Napier Advisors, Inc 1,963,920 sh (New)
Lee Ainslie 5,063,889 sh (+26.33%)
Pioneer Investments 423,231 sh (+9.39%)
Jim Simons Sold Out
Steven Cohen 697,117 sh (-58.13%)
Paul Tudor Jones 6,716 sh (-95.52%)
» More
Q2 2014

CTRX Guru Trades in Q2 2014

Manning & Napier Advisors, Inc 4,822,470 sh (+145.55%)
Vanguard Health Care Fund 4,221,183 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with CTRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Lee Ainslie 2014-03-31 Add 26.33%0.67%$44.36 - $52.59 $ 45.49-6%5063889
Vanguard Health Care Fund 2014-03-31 New Buy0.53%$44.36 - $52.59 $ 45.49-6%4221183
Joel Greenblatt 2014-03-31 New Buy0.01%$44.36 - $52.59 $ 45.49-6%9664
Lee Ainslie 2013-12-31 New Buy2.5%$44 - $50.14 $ 45.49-4%4008385
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 34.10
CTRX's P/E(ttm) is ranked higher than
73% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 50.90 vs. CTRX: 34.10 )
CTRX' s 10-Year P/E(ttm) Range
Min: 2.92   Max: 76.33
Current: 34.1

2.92
76.33
P/B 1.90
CTRX's P/B is ranked higher than
77% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 2.99 vs. CTRX: 1.90 )
CTRX' s 10-Year P/B Range
Min: 1.37   Max: 8.42
Current: 1.9

1.37
8.42
P/S 0.57
CTRX's P/S is ranked higher than
89% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 2.41 vs. CTRX: 0.57 )
CTRX' s 10-Year P/S Range
Min: 0.42   Max: 7.12
Current: 0.57

0.42
7.12
PFCF 21.70
CTRX's PFCF is ranked higher than
82% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 154.41 vs. CTRX: 21.70 )
CTRX' s 10-Year PFCF Range
Min: 9.94   Max: 124.58
Current: 21.7

9.94
124.58
EV-to-EBIT 21.33
CTRX's EV-to-EBIT is ranked higher than
75% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 35.24 vs. CTRX: 21.33 )
CTRX' s 10-Year EV-to-EBIT Range
Min: 10   Max: 66.2
Current: 21.33

10
66.2
PEG 0.80
CTRX's PEG is ranked higher than
93% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CTRX: 0.80 )
CTRX' s 10-Year PEG Range
Min: 0.55   Max: 7.95
Current: 0.8

0.55
7.95
Shiller P/E 63.90
CTRX's Shiller P/E is ranked higher than
84% of the 1825 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CTRX: 63.90 )
CTRX' s 10-Year Shiller P/E Range
Min: 8.94   Max: 119.76
Current: 63.9

8.94
119.76
Current Ratio 1.31
CTRX's Current Ratio is ranked higher than
51% of the 1659 Companies
in the Global Health Information Services industry.

( Industry Median: 1.92 vs. CTRX: 1.31 )
CTRX' s 10-Year Current Ratio Range
Min: 0.91   Max: 9.01
Current: 1.31

0.91
9.01
Quick Ratio 1.31
CTRX's Quick Ratio is ranked higher than
54% of the 1659 Companies
in the Global Health Information Services industry.

( Industry Median: 1.80 vs. CTRX: 1.31 )
CTRX' s 10-Year Quick Ratio Range
Min: 0.84   Max: 8.99
Current: 1.31

0.84
8.99

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.50
CTRX's Price/DCF (Projected) is ranked higher than
89% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CTRX: 1.50 )
CTRX' s 10-Year Price/DCF (Projected) Range
Min: 1.31   Max: 4.32
Current: 1.5

1.31
4.32
Price/Median PS Value 0.50
CTRX's Price/Median PS Value is ranked higher than
95% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 1.20 vs. CTRX: 0.50 )
CTRX' s 10-Year Price/Median PS Value Range
Min: 0.44   Max: 6.46
Current: 0.5

0.44
6.46
Price/Peter Lynch Fair Value 1.40
CTRX's Price/Peter Lynch Fair Value is ranked higher than
93% of the 1826 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. CTRX: 1.40 )
CTRX' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.33   Max: 7.63
Current: 1.4

0.33
7.63
Earnings Yield (Greenblatt) 4.50
CTRX's Earnings Yield (Greenblatt) is ranked higher than
62% of the 1390 Companies
in the Global Health Information Services industry.

( Industry Median: 5.70 vs. CTRX: 4.50 )
CTRX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.5   Max: 10
Current: 4.5

1.5
10
Forward Rate of Return (Yacktman) 44.21
CTRX's Forward Rate of Return (Yacktman) is ranked higher than
97% of the 1202 Companies
in the Global Health Information Services industry.

( Industry Median: 5.86 vs. CTRX: 44.21 )
CTRX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -17.4   Max: 49.1
Current: 44.21

-17.4
49.1

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Traded in other countries:CCT.Canada
Catamaran Corp formerly SXC Health Solutions Corporation is a provider of pharmacy benefit management services PBM and healthcare IT solutions to the healthcare benefit management industry. The Company's PBM services include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail service pharmacy claims management, specialty pharmacy claims management, Medicare Part D services, benefit design consultation, preferred drug management programs, drug review and analysis, consulting services, data access, and reporting and information analysis. The Company owns a mail service pharmacy and a specialty service pharmacy ('Ascend'). PBM services such as pharmacy network management could be provided to the company's customers using the Company's own system software and services. It provides on-line transaction processing solutions through web-enabled, real-time transaction processing technology. The Company's informed Rx offering is a suite of a la carte PBM services that provide a flexible and cost-effective alternative to traditional PBM offerings typically employed by health plans, government agencies and employers. It also provides a pharmacy spend management solutions and information technology capabilities. RxCLAIM (r) is an on-line transaction processing system designed to provide instant on-line adjudication of third-party prescription drug claims at the point of service, including trouble-free claims management and cost-effective review, as well as payment and billing support and real-time functionality for updating benefit, price, member, provider and drug details. RxCLAIM is designed to provide the company's customers with automation efficiencies, flexibility and control by facilitating the real-time processing of pharmacy claims and payments against eligibility, plan benefits, formularies, price, drug utilization review, prior authorization and rebates in addition to many other features. It is also a provider of HCIT solutions and services to providers, payers and other participants in the pharmaceutical supply chain in North America. SXC's product offerings include a range of software products for managing prescription drug programs and for drug prescribing and dispensing. The Company's solutions are available on a license basis with on-going maintenance and support or on a transaction fee basis using an ASP model. The Company's provider customers include over 1,900 independent, regional chain, institutional, and mail-order pharmacies. It is subject to state and federal statutes and regulations governing the operation of mail service pharmacies and the dispensing of controlled substances.
» More Articles for CTRX

Headlines

Articles On GuruFocus.com
Catamaran: A Safe investment for the Future Apr 24 2014 
Stocks Near Their 52-Week Low (Part 1) Apr 04 2014 
Stocks for 2014 - Something for Everyone: Part 1 Jan 10 2014 
52-Week High Companies: TD Ameritrade Holding Corporation, Catamaran Corp., Pentair Ltd., Seadrill L Aug 04 2013 
My Top 10 Fairly Valued Fast-Growing Stocks May 14 2013 
The Best Growth Investments – Low Dividends, High Growth And Return Oct 22 2012 

More From Other Websites
Nasdaq stocks posting largest volume increases Jul 31 2014
Why Catamaran Corporation (CTRX) Might Surprise This Earnings Season Jul 31 2014
Trade-Ideas: Catamaran (CTRX) Is Today's "Storm The Castle" Stock Jul 30 2014
Are Growth Stocks Appropriate For Retirement Portfolios? Jul 23 2014
Does Catamaran Stack Up To Express Scripts? Jul 18 2014
Catamaran to Host 2014 Second Quarter Conference Call Jul 17 2014
Catamaran to host 2014 second quarter conference call Jul 17 2014
Catamaran to host 2014 second quarter conference call Jul 17 2014
Citrix Using Predictive Analytics For Network Overhaul Jul 16 2014
3 Stocks Advancing The Health Care Sector Jul 11 2014
3 Stocks Dragging In The Health Services Industry Jun 25 2014
3 Stocks Improving Performance Of The Health Services Industry Jun 20 2014
Which Health Care Stock Belongs in Your Portfolio? Jun 19 2014
Catamaran Corporation Introduces Safe & Effective Compound Use Reassurance Effort Jun 16 2014
Catamaran Corporation Introduces Safe & Effective Compound Use Reassurance Effort Jun 16 2014
Wall Street Transcript Interview with Gary Quinn, the President & CEO of FalconStor Software, Inc.... Jun 10 2014
[video] Humana Pharmacy Benefit Unit Sale Could Fetch up to $7B Jun 06 2014
Catamaran to present at the Goldman Sachs Global Healthcare Conference Jun 04 2014
Catamaran to present at the Goldman Sachs Global Healthcare Conference Jun 04 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide